LGND
Companies
NASDAQ
Ligand Pharmaceuticals Inc.
Health Care
$114.64
+$7.49 (+6.99%)
Price Chart
Overview
About LGND
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Market Cap
$1.5B
Volume
14.6M
Avg. Volume
12.7M
P/E Ratio
17.54515
Dividend Yield
0.00%
Employees
94.0
Company Information
Latest News for LGND
Risk & Correlation Analysis
Market Correlation
0.71
Low Correlation
Volatility
High (0.43)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LGND shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.5B
Volume14.6M
P/E Ratio17.55
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025